Tvardi Therapeutics, Inc. (TVRD) — Net Asset Quality Index
Tvardi Therapeutics, Inc. (TVRD) has a Net Asset Quality Index of 71.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $39.02 Million minus total liabilities of $11.15 Million yields net assets of $27.87 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Tvardi Therapeutics, Inc. to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tvardi Therapeutics, Inc. Net Asset Quality Index Over Time (2020–2024)
This chart shows how Tvardi Therapeutics, Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the index stands at 71.4%, representing net assets of $27.87 Million against total assets of $39.02 Million USD. See TVRD net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Tvardi Therapeutics, Inc. (2020–2024)
The table below presents the year-by-year Net Asset Quality Index for Tvardi Therapeutics, Inc. from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Tvardi Therapeutics, Inc. stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -10.5% | $-4.59 Million | $43.83 Million | $48.42 Million | ▲ +219.4 pp |
| 2023 | -229.8% | $-62.06 Million | $27.00 Million | $89.06 Million | ▼ -129.9 pp |
| 2022 | -99.9% | $-45.05 Million | $45.10 Million | $90.15 Million | ▼ -192.0 pp |
| 2021 | 92.1% | $227.52 Million | $247.06 Million | $19.53 Million | ▲ +0.3 pp |
| 2020 | 91.8% | $249.00 Million | $271.16 Million | $22.16 Million | — |